- Autophagy acts as a maintenance apparatus which keeps the cell functioning properly by recycling "waste"
- In principle autophagy assists in protecting the organism against pathologies. Malfunctions of autophagy may on the other hand promote disease progression
- For further studying have a look at our detailed pathway poster with information to all genes involved
Autophagy is derived from Greek roots: auto, meaning 'self', and phagy, 'to eat'. This pathway is not directly a death pathway, like apoptosis, but rather a self-cannibalisation pathway. Utilizing lysosomal degradation, autophagy is responsible for cleaning the cell of unwanted proteins and degrades even complete cellular organelles. The purpose of autophagy is to maintain the homeostasis of the cell. Superfluous cell components, or even harmfully dysfunctional actors in the cells machinery are removed. Autophagy thereby acts as a maintenance apparatus that is designed to keep the cell functioning properly by removing, or rather recycling "waste".
Types of degradation
Three different types of autophagy are know which are designed to address different problems, i.e. the removal of different types of waste.
- Pexophagy, autophagy selective for degradation of peroxisomes
- Mitophagy, autophagy selective for degradation of mitochondria
- Xenophagy, autophagy selective for degradation of intracellular bacteria and viruses
Consequently autophagy is a recycling pathway that helps maintaining cellular homeostasis.
Even though autophagy has been known for over 40 years, the molecular machinery behind this process has been largely unknown until recently. Today over ~30 autophagy-related genes (ATG-genes) are known.
The cell has different ways of going about solving the problem of waste removal. Three types or processes for autophagy are knnow today.
- Microautophagy happens when lysosomes directly engulf cytoplasm
- Macroautophagy involves formation of a double-membrane structure called the autophagosome which delivers cytosolic material into the lysosome for degradation
- Chaperone-mediated autophagy (CMA) is characterized by its selectivity regarding the specific substrates (cytosolic proteins) degraded. Only proteins that have a consensus peptide sequence get recognized and degraded. In the process the substrates for degradation are transferred into the lysosome one-by-one. This process does only degrade proteins not entire organelles
Autophagy is part of everyday normal cell growth and development and is essential in helping to maintain the balance between the increase and decrease in the number of a cell content.
Purposes for autophagy
To date three main purposes or triggering events have been identified for autophagy:
- Nutrient starvation: decreased levels of amino acids can induce the autophagic processes
- Infection: autophagy plays a role in the destruction of some bacteria within the cell, and in detection of virus via pathways of the innate immune system
- Housekeeping processes: proteins and organelles are recycled
Molecular induction of autophagy
Autophagy can be induced by both internal and external stimuli. The nutrient sensor has an inhibitory effect on autophagy, under starvation conditions, is inactivated ? leading to the inhibition of autophagy being released. Hence nutrient depletion triggers autophagy. As mentioned previously, more than 30 genes have already been indicated in the actions of the signalling pathway, hence the molecular processes leading to autophagy are delicately balanced between a multitude of molecular players.
Role in disease
In principle autophagy assists in protecting the organism against pathologies, for example cancer, neurodegeneration, bacterial and viral infections, aging and heart disease. Malfunction of autophagy may therefore contribute to the development of a disease.
|Early stages ||Blocks tumor growth ||Favors tumor growthRenders cells unable to enter autophagic cell death after anticancer treatments|
|Late stages ||Favors survival of cells in low-vascularized tumorsFavors removal of damaged intracellular macromolecules after anticancer treatment ||Prevents survival of cells in low-vascular tumorsIncreases efficiency of anticancer treatments; damaged macromolecules cannot be eliminated|
|Vascular myopathies ||Promotes elimination of the cytosolic autophagic vacuoles and protein aggregate ||Results in the accumulation of autophagic vacuoles that weaken skeletal and cardiac muscles|
|Results in muscle waste if hyperactivated || |
|Early stages ||Favors removal of cytosolic protein aggregates ||Increases accumulation of cytosolic protein aggregates|
|Late stages ||Destroys damaged neurons irreversibly by cell death ||Results in accumulation of autophagic vacuoles that alter vesicular traffic|
|Axonal injury ||Favors removal of neurotransmitter versicles and damaged organelles ||Prevents removal of damaged organelles and neurotransmitter vesicles|
| ||Cytosolic release of neurotransmitters induces apoptosis|
|Provides energy and membranes for regeneration ||Slows down regeneration|
|Infectious disease ||Contributes to the elimination of bacterial and viral particles ||Offers a survival environment for the bacteria that are able to inhibit autophagosome maturationFacilitates viral infection|
Occurences favoring disease in italic font